Article
Identification of high-risk SNPs in SLC22A transporter genes: their potential role in PCOS and metformin uptake.
BMC genomic data - 17 Jun 2026
Harini R, Usha B, Satish R, Akshatha Pai, Vijaya Kumar T M
Abstract excerpt
Polycystic ovary syndrome is a prevalent, heterogeneous endocrine and metabolic disorder affecting approximately 10% of women of reproductive age, often characterized by hyperandrogenism, anovulation, and insulin resistance. Metformin, a first-line treatment for type 2 diabetes, is also widely prescribed for PCOS to reduce insulin resistance and induce ovulation. However, therapeutic response varies significantly...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
